In The News

	7/8/2010
	Globes: "I'd Like To See Teva In India and China" -- interview with Dr. Phillip Frost, Chairman of Teva and PROLOR Biotech
	6/9/2010
	Dow Jones Newswire: PROLOR Biotech Targeting Market For Long-Lasting Biopharmas
	5/26/2010
	Reuters: PROLOR Biotech to dual list on Tel Aviv bourse
	4/14/2010
	International Business Times: PROLOR Biotech Inc. (PBTH) Continues to Find Success with Peptide Technology
	2/26/2010
	The Market Oracle: Stock Market in Upward Trend
	2/2/2010
	Globes: PROLOR reports positive results in human growth hormone trial
	12/30/2009
	Roth Capital: PROLOR Among Top 3 Bioetch Firms
	12/31/2008
	Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alpha (FSH-CTP)
	7/16/2008
	CTP is "best-of-breed" for enhancing protein longevity, InPharna Technologist.com, by Gareth Macdonald
	7/8/2008
	Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
	3/31/2008
	Globes: Phillip Frost leads investment in another Israeli biomed co., by Gali Weinreb
	3/5/2008
	South Florida Business Journal: Frost buys another biotech
	10/5/2007
	Layers of Frost, FloridaTrend.com, by Mike Vogel
	9/7/2007
	Modigene and the fertility drug industry – AOL Video
	6/20/2007
	Technology for long-acting proteins here to stay, InPharna Technologist.com, by Katrina Megget
	6/20/2007
	BioCheck: Modigene: A New Biotech With Impressive Genes, StockHouse Editorials, by Leon Hamerling and J. Paul
	6/20/2007
	BioWorld Today: Modigene Financing Garners $11.6M; High Hopes For CTP
	5/16/2007
	Fierce Biotech: Frost makes another deal for biotech company
	5/16/2007
	South Florida Business Journal: Frost buys another biotech
	5/15/2007
	Ex-IVAX Chief Frost invests in firm, MiamiHerald.com, by John Dorschner